Back to Journals » Cancer Management and Research » Volume 17
LncRNA AFAP1-AS1 Modulates the Proliferation and Invasion of Gastric Cancer Cells by Regulating AFAP1 via miR-205-5p [Corrigendum]
Dang Y, Ouyang X, Ren W, Wang L, Huang Q. Cancer Manag Res. 2021;13:5163–5175.
Concerns were raised in February 2025 by a third party regarding data in the published article. The authors also contacted the journal in February 2025 regarding the error in Figure 4 on page 5172.
The authors advised due to a copy and paste error at the time of figure assembly there was an inadvertent duplication of images between the BGC-823 cells and the SGC-7901 cells in Figure 4A. The correct Figure 4 is as follows.
 |
Figure 4 Location of AFAP1-AS1 expression in GC cells and the correlation between AFAP1-AS1 and AFAP1 expression. (A) RNA FISH for the location of AFAP1-AS1 in GC cells. (B) The schematic drawing of the genomics loci of AFAP1-AS1. (C and D) The results of RT-qPCR showed that silencing of AFAP1-AS1 expression significantly decreased the expression of AFAP1 in BGC-823 and SGC-7901 cells. Data are presented as the mean±standard deviation, n = 3. *p<0.05, **p<0.01. Abbreviations: AFAP1-AS1, actin filament associated protein 1 antisense RNA1; FISH, fluorescence in situ hybridization; GC, gastric cancer; NC, scrambled siRNA; RT-qPCR, real-time quantitative polymerase chain reaction. |
The authors apologize for this error and advise it does not affect the results and conclusion of the article.
© 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 4.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.